Literature DB >> 3088564

Autonomous functions of structural domains on human tissue-type plasminogen activator.

A J van Zonneveld, H Veerman, H Pannekoek.   

Abstract

Transfected mouse Ltk- cells were employed for transient expression of recombinant human tissue-type plasminogen activator (t-PA; EC 3.4.21.31) or of recombinant-t-PA deletion proteins, encoded by SV40-pBR322-derived t-PA cDNA plasmids. The t-PA cDNA deletion mutants have two features in common, i.e., cDNA programming the signal peptide and the coding region for the light chain. Consequently, recombinant t-PA mutant proteins are efficiently secreted and display plasminogen activator activity. The gene encoding the amino-terminal heavy chain [an array of structural domains homologous to other plasma proteins (finger, epidermal growth factor, and kringle domains)] was mutated using restriction endonucleases to delete one or more structural domains. The stimulatory effect of fibrinogen fragments on the plasminogen activator activity of t-PA was demonstrated to be mediated by the kringle K2 domain and to a lesser extent by the finger/epidermal growth factor region but not by the kringle K1 domain. These data correlate well with the fibrin-binding properties of the recombinant t-PA deletion proteins, indicating that the stimulation of the activity by fibrinogen fragments is based on aligning the substrate plasminogen and t-PA on the fibrin matrix. Our results support the evolutionary concept of exon shuffling, arranging structural domains that constitute autonomous functions of the protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088564      PMCID: PMC323803          DOI: 10.1073/pnas.83.13.4670

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

2.  Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

Authors:  S Thorsen; P Glas-Greenwalt; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

3.  The primary structure of human urogastrone.

Authors:  H Gregory; B M Preston
Journal:  Int J Pept Protein Res       Date:  1977

4.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall.

Authors:  D C Rijken; G Wijngaards; J Welbergen
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

Review 5.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

6.  Why genes in pieces?

Authors:  W Gilbert
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

9.  Bovine microsomal albumin: amino terminal sequence of bovine proalbumin.

Authors:  J E Patterson; D M Geller
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

10.  Catabolism of human tissue plasminogen activator in mice.

Authors:  H E Fuchs; H Berger; S V Pizzo
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

View more
  24 in total

Review 1.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

2.  Construction and expression of a recombinant antibody-targeted plasminogen activator.

Authors:  J M Schnee; M S Runge; G R Matsueda; N W Hudson; J G Seidman; E Haber; T Quertermous
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Binding of tissue plasminogen activator to cultured human endothelial cells.

Authors:  K A Hajjar; N M Hamel; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics.

Authors:  Gaurav Ghag; Lauren M Wolf; Randi G Reed; Nicholas P Van Der Munnik; Claudius Mundoma; Melissa A Moss; Vijayaraghavan Rangachari
Journal:  Protein Eng Des Sel       Date:  2016-03-07       Impact factor: 1.650

5.  Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.

Authors:  J Wojta; M Holzer; P Hufnagl; G Christ; R L Hoover; B R Binder
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Detection of deep venous thrombosis with indium 111-labelled monoclonal antibody against tissue plasminogen activator.

Authors:  N Tromholt; B Hesse; O Folkenborg; J Selmer; N T Nielsen
Journal:  Eur J Nucl Med       Date:  1991

7.  Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.

Authors:  J M Edelberg; S V Pizzo
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

8.  A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.

Authors:  G Hartmann; L Naldini; K M Weidner; M Sachs; E Vigna; P M Comoglio; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 9.  New strategies in the development of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Blut       Date:  1988-10

10.  Interactions of a fluorescently labeled peptide with kringle domains in proteins.

Authors:  A Balciunas; G M Fless; A M Scanu; R A Copeland
Journal:  J Protein Chem       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.